Your session is about to expire
← Back to Search
Almond for Elevated Hemoglobin A1c Concentrations
Study Summary
This trial will study whether eating almonds regularly can help control blood sugar in people with elevated HbA1c.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 200 Patients • NCT01342510Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My teeth are healthy and in good condition.I am not on medication, or I have been on a stable dose for 3 months.
- Group 1: Control Group
- Group 2: Almond Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this trial currently accept new participants?
"Yes, according to the information located on clinicaltrials.gov this study is actively looking for participants. This scientific experiment was posted online on February 9th 2022 and its latest edit occurred April 18th 2022. It desires 84 individuals from a single medical centre to join their investigation."
Am I eligible to join this medical study?
"This medical trial seeks 84 qualified individuals, aged 18 to 70 and with glucose intolerance. Eligible applicants must possess the following features: no medications or a stable dosage of medication over 3 months; robust health; an absence of nut allergies; at least 4 meals per day that include one low nutrient density snack; BMI between 25-35 kg/M^2."
What goals are this clinical experiment attempting to accomplish?
"This medical study's primary endpoint is a Change in HbA1c. Subsidiary metrics include Body weight (kg), Food intake (kcal), and Insulin response to meal tolerance test (mmol/L)."
Is senior-aged participation permissible in this trial?
"To participate in this trial, individuals must be within the 18 to 70 year old age range. There are 37 trials for minors and 169 separate studies available for seniors above 65 years of age."
How extensive is the current population participating in this experiment?
"Affirmative. According to clinicaltrials.gov, this medical trial is actively looking for participants after being posted on February 9th 2022 and last updated on April 18th 2022. 84 individuals need to be enrolled from a single location."
Share this study with friends
Copy Link
Messenger